Isotopic metaprobes, nutrition, and the roads ahead

Journal of Parenteral and Enteral Nutrition

Volumn 23, Issue 4, 1999, Pages 175-194

  Young, Vernon R ^a   Ajami, Alfred M ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MassTrace   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXOPROLINASE; CYSTATHIONINE BETA SYNTHASE; DIPEPTIDYL PEPTIDASE IV; ENZYME; GAMMA GLUTAMYLTRANSFERASE; HOMOCYSTEINE; ISOTOPE; PYROGLUTAMIC ACID;

BREATH ANALYSIS; CHEMICAL STRUCTURE; CONFERENCE PAPER; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENTERIC FEEDING; ENZYME SUBSTRATE; MEDICAL RESEARCH; METABOLISM; NUTRITION; PARENTERAL NUTRITION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; ANIMAL; DIAGNOSIS; HISTORY; HUMAN; REVIEW; THERAPY;

ANIMALS; BREATH TESTS; DIAGNOSIS; HISTORY, 20TH CENTURY; HUMANS; ISOTOPES; NUTRITION PHYSIOLOGY; THERAPEUTICS;

EID: 0033061241     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607199023004175     Document Type: Conference Paper

References (134)

1. Rhoads JE: Memoir of a surgical nutritionist. JAMA 272:963-966, 1994
2. Riegel C, Koop CE, Stevens LW, et al: The nutritional requirements for nitrogen balance in surgical patients during the early postoperative period. J Clin Invest 26:18-23, 1947
3. Dudrick SJ, Wilmore DW, Vars HM, et al: Long-term total parenteral nutrition (TPN) with growth, development, and positive nitrogen balance. Surgery 64:134-142, 1968
4. Young VR: Protein and amino acid requirements in humans: Metabolic basis and current recommendations. Scand J Nutr 36:47-56, 1992
5. Young VR: Adult amino acid requirements: The case for a major revision in current recommendations. J Nutr 124:15178-15238, 1994
6. Yu Y-M, Young VR, Castillo L, et al: Plasma arginine and leucine kinetics and urea production rates in burn patients. Metabolism 44:659-666, 1995
7. Yu YM, Ryan CM, Burke JF, et al: Relations among arginine, citrulline, ornithine and leucine kinetics in adult burn patients. Am J Clin Nutr 62:960-968, 1995
8. Kien CL, Young VR, Rohrbaugh DK, et al: Increased rates of whole body protein syntheses and breakdown in children recovering from burns. Ann Surg 187:383-391, 1978
9. 13C-methionine in patients with severe burn injury. J Trauma 35:1-7, 1993
10. Young VR, Ajami A: The Rudolph Schoenheimer Centenary Lecture: Isotopes in nutrition research. Proc Nutr Soc 58:15-32, 1999
11. Schoenheimer R: The Dynamic State of Body Constituents. Harvard University Press, Cambridge, MA, 1942
12. Rittenberg D, Schoenheimer R: Studies in protein metabolism. VI. Hippuric acid formation studies with the aid of the nitrogen isotope. J Biol Chem 127:329-331, 1939
13. Folin O: A theory of protein metabolism. Am J Physiol 13:117-138, 1905
14. Schoenheimer R, Ratner S, Rittenberg D: Studies in protein metabolism. VII. The metabolism of tyrosine. J Biol Chem 127:334-344, 1939
15. Ratner S: The dynamic state of body proteins. Ann NY Acad Sci 325:189-209, 1979
16. Ciechanover A, Schwartz AI: The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death. Proc Natl Acad Sci USA 95:2727-2730, 1998
17. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 281:1312-1316, 1998
18. Hevesy G: The absorption and translocation of lead by plants. Biochem J 17:439-445, 1923
19. Hevesy G, Hofer E: Elimination of water from the human body. Nature 134:879, 1934
20. Robertson JS: Historical development. IN The Compartmental Distribution of Radiotracers. Robertson JS (ed): CRC Press, Boca Raton, FL, 1983, pp 1-9
21. Sprinson DB, Rittenberg D: The rate of interaction of the amino acids of the diet with the tissue proteins. J Biol Chem 180:715-726, 1949
22. Wolfe RR: Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. Wiley-Liss, New York, 1992
23. Aggett, PJ: Iron, copper and zinc absorption and turnover; the use of stable isotopes. Eur J Pediatr 156:829-834, 1997
24. Bier DM: Stable isotopes in biosciences, their measurement and models of amino acid metabolism. Eur J Pediatr 156:82-88, 1997
25. Bier DM: The use of stable isotopes in metabolic investigation. Ballières Clin Endocrinol Metab 1:817-836, 1987
26. Rittenberg D, Schoenheimer R: Deuterium as a indicator in the study of intermediary metabolism. II. Methods. J Biol Chem 111:169-174, 1935
27. Cohn M: Some early tracer experiments with stable isotopes. Protein Sci 4:2444-2447, 1995
28. Roth E (ed): Critical evaluation of the rise and analysis of stable isotopes (Technical Report). Pure Appl Chem 67:1753-1828, 1997
29. Effenhauser CS, Manz A: Am Lab p. 15-18, September 1994
30. Arquint P, Kovdelka-Hep M, van der Schoot BH, et al: Micromachined analyzers on a silicon chip. Clin Chem 40:1805-1809, 1994
31. McEuen PL: Carbon-based electronics. Nature 393:15-17,1998
32. Waterlow JC: Whole-body protein turnover in humans - Past, present, and future. Annu Rev Nutr 15:57-92, 1995
33. Carlson DE, Cioffi WG, Mason AD, et al: Resting energy expenditure in patients with thermal injuries. Surg Gynecol Obstet 174:270-276, 1992
34. Cunningham JJ: Factors contributing to increased energy expenditure in thermal injury: A review of studies employing indirect calorimetry. JPEN 14:649-656, 1990
35. Goran MI, Peters EJ, Herndon DN, et al: Total energy expenditure in burned children using the doubly labeled water technique. Am J Physiol 259:E576-585, 1990
36. Childs C: An analyses of thermal metabolism in burned patients. IN Physiology, Stress and Malnutrition: Functional Correlates, Nutrition Interaction. Kinney JM, Tucker HN (eds): Lippincott-Raven Publishers, New York, 1997, pp 549-569
37. Rolfe DFS, Brown GC: Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77:731-758, 1997
38. 15N] urea. Am J Clin Nutr 59:1000-1011, 1994
39. Jahoor F, Desai M, Herndon DN, et al: Dynamics of the protein metabolic response to burn injury. Metabolism 37:330-337, 1988
40. 13C]leucine. Am J Physiol 238:E473-479, 1980
41. 15N]-lysine: Response in healthy young men given excess energy intake. Metabolism 30:783-791, 1981
42. Wolfe RR, Goodenough RD, Burke JF, et al: Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg 197:163-171, 1983
43. 13C]leucine infused simultaneously by gut and by vein. Am J Physiol 260:E111-117, 1991
44. Horber FF, Haymond MW: Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 85:265-272, 1990
45. Fukagawa NK, Minaker KL, Young VR, et al: Leucine metabolism in aging humans: effect of insulin and substrate availability. Am J Physiol 256:E288-294, 1989
46. Cortiella J, Matthews DE, Hoerr RA, et al: Leucine kinetics at graded intakes in young men: Quantitative fate of dietary leucine. Am J Clin Nutr 48:998-1009, 1998
47. Wolfe RR, Durkot MJ, Allsop JR, et al: Glucose metabolism in severely burned patients. Metabolism 28:1031-1039, 1979
48. Forslund AH, Hambraeus L, Olsson RM, et al: The 24h status of whole body leucine and urea kinetics at "normal" and "high" protein intakes, with exercise in healthy adults. Am J Physiol 275:E310-320, 1998
49. El-Khoury AE, Ajami AM, Fukagawa NK, et al: Diurnal pattern of the interrelationships among leucine oxidation, urea production, and hydrolysis in humans. Am J Physiol 271:E563-573, 1996
50. El-Khoury AE, Forslund AH, Olsson R, et al: Moderate exercise at energy balance does not affect 24-h leucine oxidation or nitrogen retention in healthy men. Am J Physiol 273:E394-407, 1997
51. Wolfe RR, Herndon DN, Jahoor F, et al: Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317:403-408, 1987
52. Flatt JP: Energy costs of ATP synthesis. IN Energy Metabolism: Tissue Determinants and Cellular Corollaries, Kinney JM, Tucker HN (eds). Raven Press, Ltd., New York, 1992, pp 319-344
53. Yu Y-M, Tompkins RG, Ryan CM, et al: Metabolic considerations of the rise in energy expenditure in severe burn injury. JPEN (in press)
54. Park HS, Kelly JM, Milligan LP: Energetics and cell membranes. IN Energy Metabolism: Tissue Determinants and Cellular Corollaries. Kinney JM, Tucker HN (eds). Raven Press, New York, 1992, pp 411-435
55. + pump. Clin Sci 95:3-17, 1998
56. +-ATPaSe: Mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 269:C295-C311, 1995
57. Bertorello AM, Katz AL: Short-term regulation of renal Na-K-ATPase activity: Physiological relevance and cellular mechanisms. Am J Physiol 265:F743-755, 1993
58. Souba WW: Cytokine control of nutrition and metabolism in critical illness. Curr Prob Surg 31:577-643, 1994
59. + pump. FEBS Lett 268:314-324, 1990
60. James JH, Fang C-H, Schrantz SJ, et al: Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased lactate production in sepsis. J Clin Invest 98:2388-2397, 1996
61. +-ATPaSe activity as a cause of increased lactate production after hemorrhagic shock. J Trauma 44:796-801, 1998
62. Phillips M: Breath tests in medicine. Sci Am July, 267:74-79, 1992
63. 13C: Strategic considerations. IN New Techniques in Nutritional Research. Whitehead RG, Prentice A (eds). Academic Press, San Diego, pp 73-94
64. 13C urea breath test. Am J Gastroenterol 91:690-694, 1996
65. Fleischer B (ed): Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Function. Springer, New York, 1995
66. Goding JW, Howard MC: Ecto-enzymes of lymphoid cells. Immunol Rev 161:5-10, 1998
67. Fleischer B: CD26: A surface protease involved in T-cell activation. Immunol Today 15:180-184, 1994
68. Cunningham DF, O'Connor B: Proline specific peptidases. Biochim Biophys Acta 1943:160-186, 1997
69. Dive C: Improved methodology for intracellular enzyme reaction and inhibition kinetics by flow cytometry. Cytometry 8:552-561, 1982
70. Lucas FJ, Jaffe GE, Bott SE, et al: Method for determining activity of enzymes in metabolically active whole cells. US Patent 5,698,411 (Coulter Corp), 1997
71. Jaffe GE, Lucas FJ, Carter JH: Assay reagent. US Patent 5,776,720 (Coulter Corp), 1998
72. D'Ari R, Casadesus J: Underground metabolism. Bioassays 20:181-186, 1998
73. Yudkoff M, Blazer-Yost B, Cohn R, et al: On the clinical significance of the plasma α-amino-n-butyric acid: leucine ratio. Am J Clin Nutr 32:282-285, 1979
74. Steele RD: Transaminative metabolism of α-amino-n-butyrate in rats. Metabolism 31:318-325, 1982
75. Lapointe DS, Olson MS: α-Keto-butyrate metabolism in perfused rat liver: Regulation of a-ketobutyrate decarboxylation and effects of α-ketobutyrate on pyruvate dehydrogenase. Arch Biochem Biophys 242:417-429, 1985
76. 2 washout kinetics in acute hypercapnea. Respir Physiol 86:159-170, 1991
77. Korom S, DeMeester I, Stadlbauer THW, et al: Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63:1495-1500, 1997
78. 2+-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97:1610-1617, 1996
79. White BD, Martin RJ: Evidence for a central mechanism of obesity in the Zucker rat: Role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 214:222-232, 1997
80. Heilig M, Widerlov E: Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol 9:115-136, 1995
81. Friedman JM, Halaas JL: Leptin and the regulation of body weight in animals. Nature 395:763-770, 1998
82. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al: Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83:187-195, 1998
83. Qureshi NU, Dayao EK, Shirali S, et al: Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock. Regul Pept 75-76:215-220, 1998
84. Mentlein R, Dahms P, Grandt D, et al: Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49:134-144, 1993
85. Drucker DJ: Glucagon-like peptides. Diabetes 47:159-169, 1998
86. Holst JJ, Deacon CF: Inhibition of the activity of dipeptidyl peptidase IV as a treatment of Type 2 diabetes. Diabetes 47:1663-1670, 1998
87. Pedersen RA, White HA, Schlenzig D, et al: Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isolation thiazolidide. Diabetes 47:1253-1258, 1988
88. Meister A: Metabolism and function of glutathione. IN Glutathione: Chemical, Biochemical and Medical Aspects. Dolphin D, Poulson R, Avramovic O (eds). John Wiley & Sons, New York, 1989, pp 367-474
89. Anderson ME: Glutathione: An overview of biosynthesis and modulation. Chem Biol Interac 111-112:1-14, 1998
90. Chen X, Carystinos GD, Batist G: Potential for selective modification of glutathione in cancer chemotherapy. Chem Biol Interac 111-112:263-275, 1998
91. Taniguchi M, Hirayama K, Yamaguchi K, et al: Nutritional aspects of glutathione metabolism and function. IN Glutathione: Chemical, Biochemical and Medical Aspects, Part B. Dolphin D, Poulson R, Avramovic O (eds). John Wiley & Sons, New York, 1989, pp 645-727
92. Pena LR, Hill DB, McClain CJ: Treatment with glutathione precursor decreases cytokine activity. JPEN 23:1-6, 1999
93. Helbling B, Overbeck JV, Lauterburg BH: Decreased release of glutathione into the systemic circulation of patients with HIV infection. Eur J Clin Invest 26:38-44, 1996
94. Lenton C, Ali Z, Persaud C, et al: Infants in Trinidad excrete more 5-L-oxoproline (L-pyroglutamic acid) in urine than infants in England: An environmental not ethnic difference. Br J Nutr 80:51-55, 1998
95. Hanigan MH: γ-Glutamyl transpeptide, a glutathionase: Its expression and function in carcinogenesis. Chem Biol Interac 111-112:333-343, 1998
96. Lieberman MW, Wiseman AL, Shi Z-Z: Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 93:7923-7926, 1996
97. Durham JR, Frierson HF, Hanigan MH: Gamma-glutamyl transpeptidase immunoreactivity in benign and malignant breast tissue. Breast Cancer Res Treat 45:55-62, 1997
98. Szewczyj A, Wellman-Bednawaka M: The use of gamma-glutamyl-p-aminobenzoic acid as the substrate for determination of gamma-glutamlytranspeptidase activity in blood serum. Clin Chim Acta 84:19-26, 1978
99. Cobb MH, Heagy W, Danner J, et al: Structural and conformational properties of peptides interacting with the glutathione receptor of hydra. Mol Pharmacol 21:629-636, 1982
100. Douglas KT: Chemical synthesis of glutathione and analogs. IN Glutathione: Chemical, Biochemical and Medical Aspects, Part A. Dolphin D, Avramovic O, Poulson R (eds). John Wiley & Sons, New York, 1989, pp 243-279
101. Bodanszky M, Bodanszky A: The Practice of Peptide Synthesis. Springer-Verlag, Berlin, 1994, pp 1-217
102. Harbrecht BG, Silvio MD, Chough V, et al: Glutathione regulates nitric oxide synthase in cultured hepatocytes. Ann Surg 225:76-77, 1997
103. Castillo L, Chapman TE, Sanchez M, et al: Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci USA 90:7749-7753, 1993
104. Young VR, El-Khoury AE: The notion of nutritional essentiality of amino acids, revisited, with a note on the indispensable amino acid requirements in adults. IN Amino Acid Metabolism and Therapy in Health and Nutritional Disease. LC Cynober (ed). CRC Press, Inc., Boca Raton, FL, 1995, pp 191-232
105. 15N]citrulline labeling. Proc Natl Acad Sci USA 93:11460-11465, 1996
106. 2]arginine: Application to the response to vaccination. Am J Physiol 272:R1888-R1886, 1997
107. 15N]citrulline enrichment in human plasma using high performance liquid chromatography-mass spectrometry. Anal Biochem 257:45-52, 1998
108. Marescau B, Deshmukh D, Kockx M, et al: Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism 41:526-532, 1992
109. Marescau B, De Deyn PP, Holvoet J, et al: Gaunidino compounds in serum and urine of cirrhotic patients. Metabolism 44:584-588, 1995
110. Kato T, Sano M, Mizutani N, et al: Homocitrullinuria and homoargininuria in hyerp-argininaemia. J Inherited Metab Dis 11:261-265, 1998
111. Kato T, Sano M, Mizutani N: Homocitrullinuria and hono argininuria in lysinuric protein intolerance. J Inherited Metab Dis 12:157-161, 1989
112. Kato T, Sano M: Effect of ammonium chloride on homocitrulline and homoarginine synthesis. J Inherited Met Dis 16:906-907, 1993
113. Moali C, Boucher JL, Sari MA, et al: Substrate specificity of NO synthesases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 37:10453-10460, 1998
114. Valle D, Simell O: The hyperornithinemias. IN The Metabolic Basis of Inherited Disease. CR Scriver, AL Beadet, WS Sly, D. Valle (eds). McGraw-Hill Information Services Co., New York, 1960, pp 599-627
115. Hiramatsu T, Fukagawa NK, Marchini JS, et al: Methionine and cysteine kinetics at different intakes of cysteine in healthy adult men. Am J Clin Nutr 60:525-533, 1994
116. Raguso CA, Ajami AM, Gleason R: Effect of cysteine intake on methionine intake and oxidation, determined with oral tracers of methionine and cysteine in healthy adults. Am J Clin Nutr 66:283-292, 1997
117. Fukagawa NK, Yu Y-M, Young VR: Methionine and cysteine kinetics at different intakes of methionine and cysteine in elderly mean and women. Am J Clin Nutr 68:380-388, 1998
118. Vina J, Gimenez A, Puertes IR, et al: Impairment of cysteine synthesis form methionine in rats exposed to surgical stress Br J Nutr 68:421-429, 1992
119. Malmezat T, Breuille D, Pouyet C, et al: Metabolism of cysteine is modified during the acute phase of sepsis in rats. J Nutr 128:97-105, 1998
120. Stamler JS, Slivka A: Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev 54:1-30, 1996
121. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. New Engl J Med 338:1042-1050, 1998
122. Ferrari R, Ceconi C, Curello S, et al: Oxygen free radicals and myocardial damage: Protective role of thiol-containing agents. Am J Med 91 (Suppl 3C):95S-105S, 1991
123. Graham I, Refsum H, Rosenberg IH, et al (eds): Homocysteine Metabolism: From Basic Science to Clinical Medicine. Kluwer Academic Publishers, Boston, 1997
124. Nygard O, Nordrehaug JE, Refsum H, et al: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
125. Nilsson K, Gustafson L, Faldt R, et al: Hyperthomocysteinaemia - A common finding in psychogeriatric population. Eur J Clin Invest 26:853-859, 1996
126. Fonseca VA, Mudaliea S, Schmidt B, et al: Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism 47:686-689, 1998
127. McCully KS: Chemical pathology of homocysteine III. Cellular function and aging. Ann Clin Lab Sci 24:134-152, 1994
128. Zittoun J, Tonetti C, Bories D, et al: Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: A study in 52 healthy subjects. Metabolism 47:1413-1418, 1998
129. Barrett PHR, Bell BM, Cobelli C, et al: SAAM II: simulation, analysis and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484-493, 1998
130. Wagner JG: Pharmacokinetics for the Pharmaceutical Scientist. Technomic Publishing Co., Lancaster, PA, 1993, pp 1-316
131. Guttormsen AB, Schneede J, Ueland PM, et al: Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am J Clin Nutr 63:194-202, 1996
132. Bostom AG, Roubenoff R, Dellaripa P, et al: Validation of abbreviated oral methionine-loading test. Clin Chem 41:948-949, 1995
133. Bloom FE: Breakthroughs. Science 282:2193, 1998
134. The News and Editorial Staffs: The runners up. Science 282: 2157-2161, 1998